This item requires a subscription to Diabetes Care.
Full Text (PDF)
Emerging Treatments and Technologies:
Ralph A. DeFronzo,
Penny R. Fleck,
Craig A. Wilson,
and Qais Mekki
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic
Control: A randomized, double-blind, placebo-controlled study Diabetes Care December 2008 31:2315-2317; published ahead of print September 22, 2008, doi:10.2337/dc08-1035